文献速递艾滋病与性传播感染

宫内暴露HIV及联合抗逆转录病毒治疗的未感染儿童早期血线粒体DNA升高

Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
PubMed 文献 · J Infect Dis · 2021-01-01

本研究比较了HIV暴露未感染儿童(CHEU)与HIV未暴露未感染儿童(CHUU)出生时及生后早期(0-3岁)全血线粒体DNA含量。出生时CHEU状态与较低胎龄均与较高的mtDNA含量相关,且CHEU的mtDNA差异在出生后前3年持续可检出。作者认为这提示宫内应激的长期效应,但其临床意义尚不明确。

要点

  • CHEU出生时血mtDNA含量高于CHUU,且与较低胎龄独立相关。
  • CHEU的mtDNA水平在生后前6个月保持稳定,之后逐渐下降。
  • 年龄性别匹配分析显示两组mtDNA差异在生后前3年持续存在。

核心结论

  • CHEU中持续升高的血mtDNA含量代表一种长期效应,可能源于与母体HIV和/或cART相关的宫内应激。
  • mtDNA水平改变的临床影响尚不明确。

研究设计与样本

  • 比较CHEU与CHUU出生时及生后早期(0-3岁)全血mtDNA含量的横断面研究,并评估CHEU内mtDNA含量的纵向变化。
  • 另进行年龄和性别匹配的横断面分析,纳入214例CHEU和214例CHUU。

主要发现

  • 出生时,CHEU状态和较低胎龄与较高的mtDNA含量相关。
  • 无论分析全部婴儿还是仅足月婴儿,多变量分析中上述关联均保持独立。
  • 纵向来看,CHEU的mtDNA水平在生后前6个月保持不变,之后逐渐下降。
  • 年龄性别匹配分析显示两组间mtDNA差异在生后前3年持续可检出。

临床怎么用

  • 对CHEU进行早期及生后3年内的线粒体DNA监测可能有助于识别宫内暴露的长期影响。
  • 应关注CHEU中mtDNA升高这一实验室发现,但其临床意义尚不明确,不宜据此单独改变管理。

局限性

  • mtDNA水平改变的临床影响尚不明确。
  • 原文未报告具体样本量、数值及统计细节(除匹配分析外)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Combination antiretroviral therapy (cART) during pregnancy prevents vertical transmission, but many antiretrovirals cross the placenta and several can affect mitochondria. Exposure to maternal human immunodeficiency virus (HIV) and/or cART could have long-term effects on children who are HIV exposed and uninfected (CHEU). Our objective was to compare blood mitochondrial DNA (mtDNA) content in CHEU and children who are HIV unexposed and uninfected (CHUU), at birth and in early life. METHODS: Whole-blood mtDNA content at birth and in early life (age 0-3 years) was compared cross-sectionally between CHEU and CHUU. Longitudinal changes in mtDNA content among CHEU was also evaluated. RESULTS: At birth, CHEU status and younger gestational age were associated with higher mtDNA content. These remained independently associated with mtDNA content in multivariable analyses, whether considering all infants, or only those born at term. Longitudinally, CHEU mtDNA levels remained unchanged during the first 6 months of life, and gradually declined thereafter. A separate age- and sex-matched cross-sectional analysis (in 214 CHEU and 214 CHUU) illustrates that the difference in mtDNA between the groups remains detectable throughout the first 3 years of life. CONCLUSION: The persistently elevated blood mtDNA content observed among CHEU represents a long-term effect, possibly resulting from in utero stresses related to maternal HIV and/or cART. The clinical impact of altered mtDNA levels is unclear.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ajaykumar A, Zhu M, Kakkar F, et al. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero. J Infect Dis. 2021. PMID: 32638023. doi:10.1093/infdis/jiaa410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。